Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
78.20
+0.20 (0.26%)
At close: Mar 2, 2026
64.25%
Market Cap 13.16B
Revenue (ttm) 9.30B
Net Income (ttm) 1.26B
Shares Out 168.76M
EPS (ttm) 7.45
PE Ratio 10.47
Forward PE 10.27
Dividend 1.50 (1.92%)
Ex-Dividend Date Apr 22, 2025
Volume 201,239
Average Volume 457,278
Open 78.00
Previous Close 78.00
Day's Range 77.00 - 78.87
52-Week Range 43.60 - 87.12
Beta 0.63
RSI 40.77
Earnings Date Mar 2, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.